These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 2140060)

  • 21. Progress of fibrinolysis during tumor necrosis factor infusions in humans. Concomitant increase in tissue-type plasminogen activator, plasminogen activator inhibitor type-1, and fibrin(ogen) degradation products.
    van Hinsbergh VW; Bauer KA; Kooistra T; Kluft C; Dooijewaard G; Sherman ML; Nieuwenhuizen W
    Blood; 1990 Dec; 76(11):2284-9. PubMed ID: 1701665
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transforming growth factor beta inhibits plasminogen activator (PA) activity and stimulates production of urokinase-type PA, PA inhibitor-1 mRNA, and protein in rat osteoblast-like cells.
    Allan EH; Zeheb R; Gelehrter TD; Heaton JH; Fukumoto S; Yee JA; Martin TJ
    J Cell Physiol; 1991 Oct; 149(1):34-43. PubMed ID: 1834680
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vascular origin determines plasminogen activator expression in human endothelial cells. Renal endothelial cells produce large amounts of single chain urokinase type plasminogen activator.
    Wojta J; Hoover RL; Daniel TO
    J Biol Chem; 1989 Feb; 264(5):2846-52. PubMed ID: 2492525
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulation of plasminogen activator and plasminogen activator inhibitor production by growth factors and cytokines in rat calvarial cells.
    Cheng SL; Shen V; Peck WA
    Calcif Tissue Int; 1991 Nov; 49(5):321-7. PubMed ID: 1723649
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulation of plasminogen activation, matrix metalloproteinases and urokinase-type plasminogen activator-mediated extracellular matrix degradation in human osteosarcoma cell line MG63 by interleukin-1 alpha.
    de Bart AC; Quax PH; Löwik CW; Verheijen JH
    J Bone Miner Res; 1995 Sep; 10(9):1374-84. PubMed ID: 7502710
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of type 1 plasminogen activator inhibitor gene expression in cultured bovine aortic endothelial cells. Induction by transforming growth factor-beta, lipopolysaccharide, and tumor necrosis factor-alpha.
    Sawdey M; Podor TJ; Loskutoff DJ
    J Biol Chem; 1989 Jun; 264(18):10396-401. PubMed ID: 2499579
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Down-regulation of proteolytic activity in 12-O-tetradecanoyl-phorbol-13-acetate-induced K562 leukemia cell cultures: depletion of active urokinase by excess type 1 plasminogen activator inhibitor.
    Alitalo R; Andersson LC; Tapiovaara H; Sistonen L; Vaheri A; Stephens R
    J Cell Physiol; 1989 Jul; 140(1):119-30. PubMed ID: 2500450
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fibrinolytic activity of human mesothelial cells is counteracted by rapid uptake of tissue-type plasminogen activator.
    Sitter T; Toet K; Quax P; Kooistra T
    Kidney Int; 1999 Jan; 55(1):120-9. PubMed ID: 9893120
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prourokinase activation on the surface of human rhabdomyosarcoma cells: localization and inactivation of newly formed urokinase-type plasminogen activator by recombinant class 2 plasminogen activator inhibitor.
    Pöllänen J; Vaheri A; Tapiovaara H; Riley E; Bertram K; Woodrow G; Stephens RW
    Proc Natl Acad Sci U S A; 1990 Mar; 87(6):2230-4. PubMed ID: 2138329
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antithrombotic regulation in human endothelial cells by fibrinolytic factors.
    Fukao H; Matsuo O
    Semin Thromb Hemost; 2000; 26(1):33-8. PubMed ID: 10805279
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metastatic behavior of human melanoma cell lines in nude mice correlates with urokinase-type plasminogen activator, its type-1 inhibitor, and urokinase-mediated matrix degradation.
    Quax PH; van Muijen GN; Weening-Verhoeff EJ; Lund LR; Danø K; Ruiter DJ; Verheijen JH
    J Cell Biol; 1991 Oct; 115(1):191-9. PubMed ID: 1918136
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulation of proteolytic activity in human bone marrow stromal cells by basic fibroblast growth factor, interleukin-1, and transforming growth factor beta.
    Hannocks MJ; Oliver L; Gabrilove JL; Wilson EL
    Blood; 1992 Mar; 79(5):1178-84. PubMed ID: 1536945
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ethanol-induced up-regulation of the urokinase receptor in cultured human endothelial cells.
    Tabengwa EM; Grenett HE; Benza RL; Abou-Agag LH; Tresnak JK; Wheeler CG; Booyse FM
    Alcohol Clin Exp Res; 2001 Feb; 25(2):163-70. PubMed ID: 11236828
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hemodynamic forces modulate the effects of cytokines on fibrinolytic activity of endothelial cells.
    Kawai Y; Matsumoto Y; Watanabe K; Yamamoto H; Satoh K; Murata M; Handa M; Ikeda Y
    Blood; 1996 Mar; 87(6):2314-21. PubMed ID: 8630393
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pro- and antifibrinolytic properties of human pulmonary microvascular versus artery endothelial cells: impact of endotoxin and tumor necrosis factor-alpha.
    Muth H; Maus U; Wygrecka M; Lohmeyer J; Grimminger F; Seeger W; Günther A
    Crit Care Med; 2004 Jan; 32(1):217-26. PubMed ID: 14707582
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhancement of fibrinolytic activity of bovine aortic endothelial cells by ginsenoside Rb2.
    Liu JW; Wei DZ; Du CB; Zhong JJ
    Acta Pharmacol Sin; 2003 Feb; 24(2):102-8. PubMed ID: 12546716
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of protein kinase C and cyclic adenosine monophosphate in the regulation of tissue-type plasminogen activator, plasminogen activator inhibitor-1, and platelet-derived growth factor mRNA levels in human endothelial cells. Possible involvement of proto-oncogenes c-jun and c-fos.
    Kooistra T; Bosma PJ; Toet K; Cohen LH; Griffioen M; van den Berg E; le Clercq L; van Hinsbergh VW
    Arterioscler Thromb; 1991; 11(4):1042-52. PubMed ID: 1648385
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endotoxin induction of plasminogen activator and plasminogen activator inhibitor type 1 mRNA in rat tissues in vivo.
    Quax PH; van den Hoogen CM; Verheijen JH; Padro T; Zeheb R; Gelehrter TD; van Berkel TJ; Kuiper J; Emeis JJ
    J Biol Chem; 1990 Sep; 265(26):15560-3. PubMed ID: 2118527
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interferon-alpha 2 counteracts interleukin-1 alpha-stimulated expression of urokinase-type plasminogen activator in human foreskin microvascular endothelial cells in vitro.
    Wojta J; Zoellner H; Gallicchio M; Filonzi EL; Hamilton JA; McGrath K
    Lymphokine Cytokine Res; 1994 Apr; 13(2):133-8. PubMed ID: 8061114
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DDAVP induces systemic release of urokinase-type plasminogen activator.
    Levi M; ten Cate JW; Dooijewaard G; Sturk A; Brommer EJ; Agnelli G
    Thromb Haemost; 1989 Sep; 62(2):686-9. PubMed ID: 2510348
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.